These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 35471042)

  • 1. Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020.
    Prasad NK; Seiple IB; Cirz RT; Rosenberg OS
    Antimicrob Agents Chemother; 2022 May; 66(5):e0005422. PubMed ID: 35471042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
    Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
    Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
    Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J
    Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria.
    O'Neill AJ
    Expert Opin Investig Drugs; 2008 Mar; 17(3):297-302. PubMed ID: 18321229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed.
    Butler MS; Gigante V; Sati H; Paulin S; Al-Sulaiman L; Rex JH; Fernandes P; Arias CA; Paul M; Thwaites GE; Czaplewski L; Alm RA; Lienhardt C; Spigelman M; Silver LL; Ohmagari N; Kozlov R; Harbarth S; Beyer P
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0199121. PubMed ID: 35007139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?
    Talbot GH; Jezek A; Murray BE; Jones RN; Ebright RH; Nau GJ; Rodvold KA; Newland JG; Boucher HW;
    Clin Infect Dis; 2019 Jun; 69(1):1-11. PubMed ID: 30715222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline.
    Wang Y; Su J; Zhou Z; Yang J; Liu W; Zhang Y; Zhang P; Guo T; Li G
    Microbiol Spectr; 2023 Jun; 11(3):e0470222. PubMed ID: 37070985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
    Domalaon R; Idowu T; Zhanel GG; Schweizer F
    Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29540434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.
    Liu Y; Li R; Xiao X; Wang Z
    Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentamidine sensitizes FDA-approved non-antibiotics for the inhibition of multidrug-resistant Gram-negative pathogens.
    Wu C; Xia L; Huang W; Xu Y; Gu Y; Liu C; Ji L; Li W; Wu Y; Zhou K; Feng X
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1771-1779. PubMed ID: 32242313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America.
    Boucher HW; Talbot GH; Benjamin DK; Bradley J; Guidos RJ; Jones RN; Murray BE; Bonomo RA; Gilbert D;
    Clin Infect Dis; 2013 Jun; 56(12):1685-94. PubMed ID: 23599308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
    Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments on antibiotics for multidrug resistant bacterial Gram-negative infections.
    Voulgaris GL; Voulgari ML; Falagas ME
    Expert Rev Anti Infect Ther; 2019 Jun; 17(6):387-401. PubMed ID: 31006284
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is in the pipeline for Gram-negative pathogens?
    Talbot GH
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):39-49. PubMed ID: 18251663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver enhances antibiotic activity against gram-negative bacteria.
    Morones-Ramirez JR; Winkler JA; Spina CS; Collins JJ
    Sci Transl Med; 2013 Jun; 5(190):190ra81. PubMed ID: 23785037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration-Approved Antibiotics, 2010-2015.
    Deak D; Outterson K; Powers JH; Kesselheim AS
    Ann Intern Med; 2016 Sep; 165(5):363-72. PubMed ID: 27239977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress in development of antibiotics against Gram-negative bacteria].
    Xu ZQ; Xu ZY
    Yao Xue Xue Bao; 2013 Jul; 48(7):993-1004. PubMed ID: 24133966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics in the clinical pipeline in 2011.
    Butler MS; Cooper MA
    J Antibiot (Tokyo); 2011 Jun; 64(6):413-25. PubMed ID: 21587262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.